JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 59 filers reported holding JANUX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,342,236 | -15.3% | 331,571 | -0.3% | 0.00% | – |
| Q2 2023 | $3,947,843 | +9.3% | 332,590 | +11.4% | 0.00% | – |
| Q1 2023 | $3,613,411 | -51.5% | 298,629 | -47.3% | 0.00% | – |
| Q4 2022 | $7,457,118 | +108.5% | 566,220 | +114.3% | 0.00% | – |
| Q3 2022 | $3,577,000 | +10.9% | 264,207 | +0.1% | 0.00% | – |
| Q2 2022 | $3,224,000 | -7.1% | 264,022 | +9.1% | 0.00% | – |
| Q1 2022 | $3,470,000 | -16.9% | 241,998 | +14.4% | 0.00% | – |
| Q4 2021 | $4,174,000 | +10.5% | 211,566 | +21.1% | 0.00% | – |
| Q3 2021 | $3,778,000 | – | 174,644 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 9,165,652 | $92,389,772 | 1.82% |
| BVF INC/IL | 4,579,818 | $46,164,565 | 1.24% |
| Samsara BioCapital, LLC | 360,414 | $3,632,973 | 1.11% |
| Orbimed Advisors | 3,317,927 | $33,444,704 | 0.71% |
| Old Well Partners, LLC | 10,300 | $103,824 | 0.09% |
| Corton Capital Inc. | 11,061 | $111,495 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,150,000 | $11,592,000 | 0.03% |
| XTX Topco Ltd | 13,636 | $137,451 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,067,468 | $20,823,593 | 0.01% |
| Alyeska Investment Group, L.P. | 175,000 | $1,764,000 | 0.01% |